Valo Therapeutics has announced the acquisition of intellectual property rights for the ‘PeptiBAC’ technology from the University of Helsinki, Finland. "We have a strong and enduring innovation partnership with the University of Helsinki, based on our PeptiCRAd and PeptiENV technologies. JustAlready a subscriber Login You have read all your free…
[…] If you are a subscriber you may read the interview here! […]